Benjamin Chuah
Dr. Chuah’s subspecialty interest is in Gastrointestinal Cancers including oesophageal, gastric, biliary tract, pancreatic, liver and colorectal cancers.
Dr. Benjamin Chuah, Consultant Medical Oncologist at OncoCare Cancer Centre, was previously Consultant in the Department of Haematology-Oncology, National Cancer Institute Singapore, National University Hospital.
Graduating in medicine from Trinity College Dublin in 1998 where he was awarded the Professor Prize in Physic (Surgery) and the Arthur Ball Prize (2nd Place), Dr. Chuah returned to Singapore and obtained his Membership of the Royal College of Physicians of the United Kingdom in 2002.
Dr. Ben Chuah’s subspecialty interest is in Gastrointestinal Cancers including oesophageal, gastric, biliary tract, pancreatic, liver (hepatocellular carcinoma), neuroendocrine cancers and colorectal cancers. As a clinical cancer specialist and researcher, his research work includes small cell gallbladder cancer with paraneoplastic hyponatremia, exploring the lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma, renal cell carcinoma (kidney cancer) with bony metastases and use of the chemotherapy drug, docetaxel (Taxotere) with or without ketoconazole in breast cancer. He has published on screening in colorectal cancer and was involved in a randomized, phase 2 study of ganitumab or conatumumab in combination with FOLFIRI (5-FU, leucovorin, irinotecan) for second-line treatment of mutant KRAS metastatic colorectal cancer.
- MBBCH
- BAO (Ireland)
- MRCP (United Kingdom)
- FRCP (Edinburgh)
- FRCP (Medical Oncology)
English
Opening Hours
Accepted Insurance
AIAAXAAllianzFullertonGreat EasternMHCNTUC IncomeParkway ShentonPrudential
Accepted Panel
GetDoc
Our Website
Our Story
Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy.
We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology.
Our core values are excellence, compassion and integrity.